As discussed in paragraphs dedicated to breast cancer and colorectal entities, these observations have raised the possibility that FOXP2 might actively be part of a protective network of factors involved in preventing pro-oncogenic processes - at least in some tissues. Here, FOXP2 is linked to breast carcinoma.